Skip to main navigation
Replimune
  • Our Science
  • Pipeline
  • Our Team
  • Clinical Trials
  • Medical Affairs
  • Careers
  • Contact
  • Investors & Media
    • Overview
    • Events and Presentations
    • Press Releases
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Publications
    • Email Alerts
    • Investor Contact
Select Page

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
Feb 14, 2019
Document Date
Feb 12, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Replimune
Issuer
Replimune Group, Inc.
Filer
Atlas Venture Fund X, L.P.

Filing Formats

View HTML
Download PDF
Download DOC
Print Page
RSS Feeds RSS Feeds
Email Alerts Email Alerts
Contact IR Contact IR
Search Search

© 2021 Replimune Group Inc | 500 Unicorn Park Dr, 3rd Floor, Woburn, MA 01801 | Stay Connected:

Privacy | Terms